Patient Perception Study for AL-4943A

Summary

To evaluate patient perceptions of Al-4943 in subjects with allergic conjunctivitis previously treated with a topical ocular anti-allergy leukotriene-release inhibitor medication.

Timeline

Start

2010-09

Primary completion

2011-10

Completion

2011-10

Drugs

Indications